Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unravelling the Local and Systemic Effects of Primary Surgery and Perioperative Use of Ketorolac and Pregabalin in Primary Breast Cancer Patients According to Adiposity

NCT06150898 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT06150898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unravelling the Local and Systemic Effects of Primary Surgery and Perioperative Use of Ketorolac and Pregabalin in Primary Breast Cancer Patients According to Adiposity
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Recruiting
Start date
May 12, 2025
Completion date
October 31, 2027
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer, estrogen-receptor-positive breast cancer